

Maxime Samson
319 posts

@Maxime_Samson21
MD PhD / Prof of Internal Medicine / National Referal Center #autoimmune diseases #SNFMI #GFEV #GEFA @CHUDijon @univbourgogne




Presented at the 15th European Lupus Meeting: In patients with SLE without advanced lupus nephritis, obinutuzumab plus standard therapy was superior to placebo plus standard therapy in conferring and sustaining a clinically meaningful reduction in disease activity over 52 weeks. Full phase 3 ALLEGORY trial results: nejm.org/doi/full/10.10… #SLEuro | @SLEuroSociety








As Erdheim-Chester Disease (ECD) becomes more recognized and understood within the medical community, a new challenge is emerging: what happens when a patient’s symptoms don’t follow a predictable pattern, or worse, when ECD isn’t the only condition ... erdheim-chester.org/keynote-spotli…











